The Pharmacovigilance Risk Assessment Committee (PRAC) convened from September 25th to 28th, 2023, to review critical safety data. Among the significant outcomes was the decision…
We value your input and always appreciate feedback. Your suggestions and comments help us improve our services, ensuring that we consistently meet your needs and exceed your expectations.
![]() |
MO - FR 9:00 am - 5:00 pm |
![]() |
|
![]() |
|
![]() |
Czech Republic, |